Members of the Tennessee Board of Pharmacy discussed several options to increase oversight of sterile compounding pharmacies in the wake of last year's deadly multistate outbreak of fungal meningitis that has sickened hundreds of people across the country. During a Thursday meeting in Nashville, board members weighed proposals from the state Department of Health, including changes to pharmacy licenses. It was stressed that there is a need for more investigators to ensure facilities are sterile. Doctors in Tennessee were the first to link the meningitis outbreak to steroid injections prepared by a Massachusetts compounding pharmacy, which also had a pharmacy license in Tennessee until it was revoked. Across the country, 45 people, including 14 in Tennessee, have died after getting the shots. (bg)